Thyme Care, a Nashville, TN-based value-based cancer care partner, raised $60 million in Series B funding, per Fortune’s Term Sheet. Town Hall Ventures and Foresite Capital led the round and were joined by Andreessen Horowitz Bio + Health, AlleyCorp, Casdin Capital, and Frist Cressey Ventures.
Thyme Care’s B Round Nets $60M
